Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.

Science Creates Ventures 2a Lp investment portfolio

Science Creates Ventures 2a Lp has made numerous investments in companies such as Scarlet Therapeutics, Delta G, and Phovir Technologies within the Biotech sector.

vc
Portfolio
6
Team
0

Portfolio (6)

CompanySectorCitySourceLast confirmed on
Bitrobius Genetics Ltd
Bitrobius Genetics develops the Gentrafix™ platform, a plasmid‑based technology that delivers therapeutic DNA to every affected cell through intercellular transmission, aiming to treat genetic diseases, including those caused by mitochondrial gene mutations. The company targets the gene‑therapy market for diseases that currently have no effective treatments.
Healthcare & Life SciencesMacclesfieldConfirmed2025-11-23
Delta G Limited
DELTA G LIMITED is a UK-based quantum sensing company that develops quantum gravity sensors and gravity sensing hardware. Their primary product is a quantum gravity gradiometer, an underground imaging system that uses quantum technology to measure gravity gradients for accurate mapping and navigation. The company targets sectors such as infrastructure, transportation, energy, and defense, providing spatial intelligence for subsurface imaging, navigation, and environmental monitoring in various environments, including those where GPS is unavailable.
Industrials & ManufacturingBirminghamConfirmed2026-02-27

Sign up to see the full portfolio

+4 more companies

Sign up

Shareholding changes (6)

Science Creates Ventures 2a Lp's positions across portfolio companies
2026

Sign up free to see when this investor has bought or sold shares.

+4 more changes

Sign up

Articles (2)